← Browse by Condition
Medical Condition

colitis ulcerative

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 2, Phase 3, Phase 3

ClinicalMetric tracks all active clinical trials for colitis ulcerative sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — colitis ulcerative Clinical Trials

How many clinical trials are currently recruiting for colitis ulcerative?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for colitis ulcerative, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for colitis ulcerative?
colitis ulcerative research spans Phase 2 (4 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a colitis ulcerative clinical trial?
Eligibility criteria for colitis ulcerative trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
4
Phase 3
2
Top Sponsors
University of Aarhus 1 trial
Eli Lilly and Company 1 trial
Sanofi 1 trial
Pfizer 1 trial
Eisai Korea Inc. 1 trial

Recruiting Clinical Trials

NCT07338565
Recruiting
Magnesium in Gastrointestinal Disease
Enrollment
120 pts
Location
Denmark
Sponsor
University of Aarhus
View Trial →
NCT07483073 Phase 2
Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Enrollment
60 pts
Location
United States, Belgi...
Sponsor
Eli Lilly and Company
View Trial →
NCT06867094 Phase 2
Recruiting
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Enrollment
204 pts
Location
United States, Argen...
Sponsor
Sanofi
View Trial →
NCT06294925
Recruiting
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Enrollment
360 pts
Location
Canada, Germany, Uni...
Sponsor
Pfizer
View Trial →
NCT06246123
Recruiting
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Enrollment
2,040 pts
Location
South Korea
Sponsor
Eisai Korea Inc.
View Trial →
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Enrollment
120 pts
Location
United States, Austr...
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07012395 Phase 2
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Enrollment
645 pts
Location
United States, Argen...
Sponsor
Spyre Therapeutics, Inc.
View Trial →
NCT07196748 Phase 3
Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Enrollment
882 pts
Location
United States, Argen...
Sponsor
Janssen Research & Development...
View Trial →

Related Conditions

colitis ulcerosa (1) crohns disease (1) morbus crohn (1) ileostomy stoma (1) ileostoma (1) ileostomies (1) bile acid diarrhea (1) bile acid malabsorption (1) magnesium deficiency (1) magnesium level (1) magnesium (1) crohn disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology